MedTrace Logo

Effects of Probiotics on Neonatal Hyperbilirubinemia

NCT02807246 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-06-21

No results posted yet for this study

Summary

This study was designed as a prospective controlled study to investigate the effects of probiotic support started immediately after birth on newborn jaundice in breastfed babies born by normal spontaneous vaginal delivery.

Conditions

  • Neonatal Hyperbilirubinemia

Interventions

BIOLOGICAL

Maflor®, Mamsel Pharmaceuticals, Turkey

Dietary Supplement: Probiotics probiotics at a dose of 1x109 CFU/day. (Maflor®, Lactobacillus rhamnosus GG 109 CFU, Mamsel Pharmaceuticals, Turkey) Other Name: Maflor®

OTHER

drops of saline

Dietary Supplement: Breast milk +drops of saline

Sponsors & Collaborators

  • Karadeniz Technical University

    lead OTHER

Principal Investigators

  • Yakup Aslan · Division of Neonatology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
10 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-12-31
Completion
2016-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807246 on ClinicalTrials.gov